medigraphic.com
ISSN 0016-3813 (Print)

2002, Number 4

<< Back Next >>

Gac Med Mex 2002; 138 (4)

Survival in Patients with Liver Cirrhosis at the Durango, México IMSS Regional General Hospital.

Rodríguez-Hernández H, Jacobo-Karam JS, Castañón-Santillán MC, Arámbula-Chávez M, Martínez-Aguilar G

Language: Spanish
References: 20
Page: 325-330
PDF size: 107.94 Kb.


ABSTRACT

Introduction: In Mexico, hepatic cirrhosis mortality exhibits important regional differences. Aim: To analyze global survival of cirrhotic patients, according to etiology and functional status. Material and methods: Between March 1990 to August 1998, newly diagnosed patients with hepatic cirrhosis were included in a follow-up study. Subjects were analyzed monthly. Information on clinical evolution, complications, and dates of events (death) and complications were registered. Survival was estimated using Kaplan-Meier method. Results: Ninety nine subjects were included in the survival analysis, 66 with alcoholic and 33 with viral cirrhosis (HCV and HBV in 24 and nine patients, respectively). Ninety seven percent of patients were decompensated at diagnosis, and 81% had ascites. Probabilities for survival in the entire series were 69.7, 37.6 and 23.6% at 24, 48, and 60 months, respectively. There were no significant differences in the survival of patients grouped according to etiology. When survival was analyzed by Child-Pugh score, it was slightly higher in the alcoholic cirrhosis group. Conclusions: In this study survival probability of patients with viral cirrhosis was lower than in patients with alcohol cirrhosis.


REFERENCES

  1. 1. Sherlock S. European livers. Lancet 1993;342:1127-28.

  2. 2. Younossi ZM, Guyatt G. Quality-of-life assessments and chronic liver disease. Am J Gastroenterol 1998;93:1037-41.

  3. 3. Aspectos relevantes sobre la estadística de egresos hospitalarios del Sistema Nacional de Salud. Dirección General de Estadística e Informática de la Secretaría de Salud, México. Salud Pública Mex 1997;39:162-74.

  4. 4. Rodríguez-Hernández H, Guerrero-Romero JF, Jacobo-Karam JS, Rodríguez-Morán M. Análisis de supervivencia en pacientes cirróticos. Rev Gastroenterol Mex 1996;61: 226-32.

  5. 5. Propst A, Propst T, Zangerl G, Öfner D, Judrnaier G, Vogel W. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci 1995;40:1805-15.

  6. 6. Campollo O, Valencia-Salinas JJ, Berumen-Arellano A, Pérez-Aranda MA, Panduro-Cerda A, Segura-Ortega J. Características epidemiológicas de la cirrosis hepática en el Hospital Civil de Guadalajara. Salud Pública Mex 1997;39:195-200.

  7. 7. Kershenobich D, García-Tsao G. Alvarez-Saldaña S, Rojkind M. Relationship between blood lactic acid and serum proline in alcoholic liver cirrhosis. Gastroenterology 1981-80:1012-18.

  8. 8. Narro-Robles J, Gutiérrez-Avila JH, López-Cervantes M, Borges G, Rosovsky H, La mortalidad por cirrosis hepática en México 1. Características epidemiológicas relevantes. Salud Pública Mex 1992;34:378-87.

  9. 9. Narro-Robles J, Gutiérrez-Avila JH. Correlación ecológica entre consumo de bebidas alcohólicas y mortalidad por cirrosis hepática en México. Salud Pública Mex 1997;39:217-20.

  10. Narro-Robles J, Gutiérrez-Avila JH, López-Cervantes M, Borges G, Rosovsky H. La mortalidad por cirrosis hepática en México Il. Exceso de mortalidad y consumo de pulque. Salud Pública Mex 1992;34:388-405.

  11. Principales resultados de la estadística sobre mortalidad en México, 1997. Dirección General de Estadística e Informática de la Secretaría de Salud, México. Salud Pública Mex1998;40:517-23.

  12. Niedarau C, Lange S, Heintges T, Erchardt A, Buschkamp M, Hürter D, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998;28:1687-95.

  13. Lee WM. Hepatitis B. N Engl J Med 1997;337:1733-46.

  14. Salerno F, Borroni G. Moser P, Badalamenti S, Cassara L, Maggl A, et al. Survival prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993;88:514-19.

  15. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Sem Liv Dis 2000;20:17-35.

  16. Wands JR, Blum HE. Hepatitis B and C virus and alcohol-induced Iiver injury. Hepatology 1991;14:730-33.

  17. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122-28.

  18. D'Amico G, Morabito A, Pagllaro L, Marubini E. The Liver Group "V Cervello Hospital". Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468-75.

  19. Kershenobich D. Orillac J. Alcohol e hígad. Rev Gastroenterol Mex 1982.47:149-53.

  20. Borowsky SA, Strome S, Lott E. Continued heavy drinking survival in alcoholic cirrhotics. Gastroenterology 1981; 180:1405-09.




2020     |     www.medigraphic.com